HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara Jarzab Selected Research

Angiopoietin-2

1/2016A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
8/2015A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara Jarzab Research Topics

Disease

42Neoplasms (Cancer)
12/2023 - 01/2004
34Thyroid Neoplasms (Thyroid Cancer)
12/2023 - 08/2003
11medullary Thyroid cancer
11/2023 - 05/2005
9Disease Progression
11/2023 - 08/2009
9Neoplasm Metastasis (Metastasis)
01/2021 - 08/2003
8Carcinoma (Carcinomatosis)
06/2014 - 01/2004
7Adenoma (Adenomas)
11/2016 - 01/2004
7Follicular Adenocarcinoma
11/2016 - 01/2004
6Hypertension (High Blood Pressure)
12/2022 - 01/2012
5Fatigue
12/2022 - 10/2013
5Papillary Thyroid Cancer
06/2020 - 05/2005
5Diarrhea
01/2016 - 01/2012
5Nausea
01/2016 - 01/2012
4follicular Thyroid cancer
06/2017 - 11/2010
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2017 - 01/2008
4Carcinoid Tumor (Carcinoid)
01/2015 - 01/2008
4Nodular Goiter
01/2005 - 01/2004
3Lymphatic Metastasis
11/2019 - 06/2007
3Graves Disease (Basedow Disease)
10/2019 - 05/2006
3Paraganglioma (Paragangliomas)
04/2015 - 05/2008
3Pheochromocytoma
10/2010 - 05/2008
2Breast Neoplasms (Breast Cancer)
01/2016 - 01/2011
2Sarcoma (Soft Tissue Sarcoma)
08/2015 - 02/2012
2Exanthema (Rash)
07/2014 - 01/2012
2Anaplastic Thyroid Carcinoma
02/2014 - 12/2012
2Adenocarcinoma
01/2012 - 01/2009
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2010 - 01/2010
2Glioma (Gliomas)
06/2006 - 01/2002
2Thyroid Diseases (Thyroid Disease)
02/2005 - 01/2002
1Dysgeusia (Parageusia)
01/2016
1Body Weight (Weight, Body)
01/2016
1Triple Negative Breast Neoplasms
01/2016
1Deglutition Disorders (Dysphagia)
01/2016

Drug/Important Bio-Agent (IBA)

6cabozantinibIBA
12/2023 - 10/2013
6lenvatinibIBA
12/2023 - 01/2015
6RacivirIBA
06/2017 - 01/2004
6DNA (Deoxyribonucleic Acid)IBA
01/2011 - 05/2005
5Phosphotransferases (Kinase)IBA
08/2017 - 12/2014
5Proteins (Proteins, Gene)FDA Link
06/2014 - 01/2004
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 01/2008
4Calcitonin (Calcitonin, Eel)FDA LinkGeneric
12/2020 - 04/2015
4Tyrosine Kinase InhibitorsIBA
03/2017 - 10/2013
4Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2015 - 08/2003
4Thyrotropin AlfaFDA LinkGeneric
12/2015 - 08/2003
4OligonucleotidesIBA
10/2009 - 02/2005
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2024 - 08/2009
3Sorafenib (BAY 43-9006)FDA Link
12/2023 - 07/2014
3Biomarkers (Surrogate Marker)IBA
12/2020 - 10/2010
3MicroRNAs (MicroRNA)IBA
11/2016 - 02/2009
3ThyroglobulinFDA Link
06/2007 - 01/2002
2vandetanib (ZD6474)IBA
11/2023 - 01/2012
2Radioisotopes (Radionuclides)IBA
01/2022 - 01/2008
2Capsules (Microcapsules)IBA
01/2022 - 09/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2017 - 03/2017
2ParaffinIBA
06/2017 - 10/2013
2Formaldehyde (Formol)FDA Link
06/2017 - 10/2013
2Angiopoietin-2IBA
01/2016 - 08/2015
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2016 - 01/2007
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2015 - 08/2009
2Octreotide (Sandostatin)FDA LinkGeneric
01/2015 - 09/2009
2IodineIBA
07/2014 - 01/2002
2fosbretabulin (combretastatin A4)IBA
02/2014 - 12/2012
2Calcium-Binding ProteinsIBA
02/2012 - 01/2009
2Isotretinoin (Accutane)FDA LinkGeneric
08/2009 - 08/2003
2Thyroxine (Levothyroxine)FDA LinkGeneric
09/2007 - 02/2004
2Thyroid HormonesIBA
07/2006 - 03/2005
2Monoclonal AntibodiesIBA
06/2006 - 01/2004
1selpercatinibIBA
11/2023
1Peptide Receptors (Peptide Receptor)IBA
01/2022
1TabletsIBA
01/2022
1Codon (Codons)IBA
01/2021
1Carcinoembryonic AntigenIBA
12/2020
1trans-crotonin (CTN)IBA
12/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
06/2020
1tyrosine receptor (receptor, tyrosine)IBA
01/2017
1lanreotide (Somatuline)FDA Link
01/2017
1Peptides (Polypeptides)IBA
01/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
1AlbuminsIBA
01/2016
1Alanine Transaminase (SGPT)IBA
01/2016
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2016
1Hormones (Hormone)IBA
01/2016
1Cytochrome P-450 CYP3AIBA
01/2016
1Interleukin-8 (Interleukin 8)IBA
01/2016
1Becaplermin (PDGF-BB)FDA Link
01/2016
1Alkaline PhosphataseIBA
01/2016
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2015
1SynaptophysinIBA
04/2015
1Keratins (Keratin)IBA
04/2015
1ChromograninsIBA
04/2015
1raf KinasesIBA
03/2015

Therapy/Procedure

22Therapeutics
12/2023 - 08/2003
8Thyroidectomy
01/2019 - 11/2005
6Drug Therapy (Chemotherapy)
10/2019 - 06/2006
4Radiotherapy
11/2019 - 01/2002
3Lymph Node Excision (Lymph Node Dissection)
11/2010 - 11/2005
2Radioimmunotherapy
06/2006 - 01/2002
1Lasers (Laser)
01/2020
1Adjuvant Radiotherapy
11/2019
1Neoadjuvant Therapy
01/2016